These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 66418)
1. Controlling the spread of leprosy--some observations on. Dharmendra Lepr India; 1976 Jul; 48(3):217-30. PubMed ID: 66418 [No Abstract] [Full Text] [Related]
2. Leprosy control based on multi drug treatment in India. Rao CK; Mittal BN; Dharmshaktu NS Indian J Lepr; 1988 Apr; 60(2):290-302. PubMed ID: 3192979 [No Abstract] [Full Text] [Related]
3. Evaluation of drug regimen in lepromatous leprosy--II. Ramu G; Sreevatsa Lepr India; 1983 Apr; 55(2):200-8. PubMed ID: 6195452 [TBL] [Abstract][Full Text] [Related]
4. Multidrug therapy (MDT) and leprosy control. Noordeen SK Indian J Lepr; 1990; 62(4):448-58. PubMed ID: 2086680 [No Abstract] [Full Text] [Related]
7. Leprosy at a turning point? Harboe M Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):312-8. PubMed ID: 11221095 [No Abstract] [Full Text] [Related]
8. Some thoughts on the present status and future prospects of chemotherapy of leprosy based on experience with treating tuberculosis. Acocella G Int J Lepr Other Mycobact Dis; 1981 Sep; 49(3):331-40. PubMed ID: 7198623 [No Abstract] [Full Text] [Related]
9. [Chemotherapy of leprosy. I. Sulfones and sulfonamides]. Leiker DL Ned Tijdschr Geneeskd; 1979 Jun; 123(23):969-72. PubMed ID: 460449 [No Abstract] [Full Text] [Related]
10. Studies on sulfone resistance in leprosy. I. Detection of cases. Pettit JH; Rees RJ; Ridley DS Int J Lepr Other Mycobact Dis; 1966; 34(4):375-90. PubMed ID: 6006069 [No Abstract] [Full Text] [Related]
12. Drug resistance of Mycobacterium leprae, particularly to DDS. Rees RJ Int J Lepr Other Mycobact Dis; 1967; 35(4):625-38. PubMed ID: 4173566 [No Abstract] [Full Text] [Related]
13. Dapsone drug resistance in the MDT era. Roche PW; Neupane KD; Failbus SS; Butlin CR Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097 [No Abstract] [Full Text] [Related]
14. [Response to the short-course chemotherapy in patients presenting initial resistance]. Mitchison DA Bull Int Union Tuberc; 1985; 60(1-2):41-3. PubMed ID: 2416375 [No Abstract] [Full Text] [Related]
15. Priorities for the future and prospects for leprosy control. Becx-Bleumink M Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):82-101. PubMed ID: 8326185 [No Abstract] [Full Text] [Related]
16. Ethionamide, prothionamide and thiacetazone self-administration. Studies of patient compliance using isoniazid-marked formulations. Stanley JN; Pearson JM; Ellard GA Lepr Rev; 1986 Mar; 57(1):9-18. PubMed ID: 2422517 [No Abstract] [Full Text] [Related]
17. Leprosy elimination in India--so near. Rao CK Indian J Lepr; 2005; 77(3):207-11. PubMed ID: 16353518 [No Abstract] [Full Text] [Related]
18. Prevalence of drug resistance in Dharmapuri and A. Pallipatti areas of Tamil Nadu. Sreevatsa ; Ramu G; Desikan KV Indian J Lepr; 1985; 57(2):376-82. PubMed ID: 3908580 [TBL] [Abstract][Full Text] [Related]
19. Can leprosy be eradicated with chemotherapy? An evaluation of the Malta Leprosy Eradication Project. Jacobson RR; Gatt P Lepr Rev; 2008 Dec; 79(4):410-5. PubMed ID: 19274987 [TBL] [Abstract][Full Text] [Related]
20. Regarding Brasil, et al.'s adverse effects in leprosy's WHO/MDT and paramedic's role in leprosy control program. Cunha Mda G; Schettini AP; Pereira ES; Pedrosa VL; Cruz RC; Sadahiro M Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):257-9. PubMed ID: 9251600 [No Abstract] [Full Text] [Related] [Next] [New Search]